Skip to main content

3 Result(s)

within Paul F. Robbins Remove this filter Medicine & Public Health Remove this filter Cancer Research Remove this filter

and

  1. No Access

    Article

    Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression

    The therapeutic use of T cell receptor (TCR)-transduced peripheral blood lymphocytes (PBL) targeting tumor-associated antigens is emerging as a promising investigational treatment for patients with cancer. Ini...

    Jennifer A. Wargo, Paul F. Robbins, Yong Li… in Cancer Immunology, Immunotherapy (2009)

  2. Article

    A listing of human tumor antigens recognized by T cells

    Nicolina Renkvist, Chiara Castelli, Paul F. Robbins… in Cancer Immunology, Immunotherapy (2001)

    Download PDF (144 KB)

  3. Article

    Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies

    The MC-38 C57BL/6 mouse colon adenocarcinoma cell line has been transduced with a retroviral construct containing cDNA encoding the human carcinoembryonic antigen (CEA) gene [Robbins PF, Kantor JA, Salgaller M...

    Patricia Horan Hand, Paul F. Robbins… in Cancer Immunology, Immunotherapy (1993)

    Download PDF (1208 KB)